Cold Chain in Peptide Shipping

The cold chain in peptide shipping determines whether the material that reaches the laboratory carries the purity stated on the certificate of analysis, or whether it degraded in transit. Lyophilized peptides tolerate temperature ranges that peptides in solution cannot, but that tolerance has defined limits. In an international shipment, the most unpredictable segment is usually not the flight — it is the hold at customs.

PeptoClinic supplies research peptides in lyophilized vial format, with per-lot documentation from Janoshik Analytical. This post describes what that means for thermal control: from vial sealing at origin through verification at the receiving laboratory.

Why temperature matters for peptides

Peptides are chains of amino acids joined by peptide bonds. Those bonds are susceptible to hydrolysis — chemical cleavage by water — and to oxidation. Both reactions are temperature-sensitive: higher heat combined with longer exposure accelerates degradation. The result is not a vial with reduced content. It is a vial containing molecular fragments that are no longer the original compound and are therefore not suitable for research.

Thermal degradation does not require extreme conditions. Some peptides begin showing degradation products at sustained exposure above 25 °C. The rate depends on the amino acid sequence, on whether the molecule contains particularly sensitive structures such as disulfide bonds, and on the residual moisture level in the powder.

Lyophilized versus solution: two different requirements

A peptide in aqueous solution is vulnerable from the moment of reconstitution. Water activates every degradation pathway simultaneously — hydrolysis, oxidation, aggregation — and the useful life of the material is measured in hours or days. Shipping it requires unbroken active cold-chain at −20 °C or below.

A lyophilized peptide is a different situation. The freeze-drying process removes water under vacuum, leaving residual moisture typically below 1 %. Without free water, most degradation reactions stop. The material can tolerate transit temperatures between 2 °C and 25 °C without significant purity loss, provided the vial is correctly sealed and the exposure window is bounded. The precise range varies by compound.

PeptoClinic ships exclusively in lyophilized format. That extends the stability window during international transport and reduces the risk created by unpredictable customs delays.

What happens during shipping

Vial sealing

The starting point is the simplest and the most critical: the vial must be sealed with a crimp cap at low residual humidity. A vial that loses its seal during transport — from vibration, extreme temperature, or a manufacturing defect — absorbs ambient moisture and begins degrading regardless of how well temperature was controlled throughout the journey.

Thermal packaging

To offset temperature variation during transit — cold aircraft hold, warm ground depot, ambient-temperature delivery vehicle — the package carries thermal insulation. The type of material depends on the route and the time of year. A January shipment to Buenos Aires has a different thermal profile than a July one.

Packages using phase-change materials — refrigerant gels designed to hold a specific range — are more controllable than dry ice, which can super-cool and requires additional declarations in the customs documentation of many countries.

Temperature indicators

Some shipments carry physical temperature indicators: devices or labels that record whether the declared range was exceeded at any point in transit. An activated indicator does not prove the material degraded — it proves a thermal excursion occurred. The decision to use or reject the lot rests with the responsible investigator and the receiving laboratory.

The riskiest segment: customs

The most unpredictable link in the cold chain for a shipment to Argentina is the customs hold. A package entering through Ezeiza can clear in hours or remain held for several days because of an inspection, a documentation issue, or a tariff classification that requires clarification.

Documentation is the variable the supplier can control. PeptoClinic prepares the dispatch so that the material enters as laboratory reference material — the correct classification for research compounds — rather than as a medicine or supplement. That distinction directly affects hold time: medicines require authorizations this material does not have and is not intended to have, and they are routed through slower verification channels.

A correctly classified lot with complete documentation flows through dispatch paths that a mislabeled lot cannot access. The cold chain survives customs when the documentation is correct from the outset.

How PeptoClinic handles Argentine shipments — including import documentation — is described on the Argentina shipping page.

What to check when the package reaches the laboratory

Vial integrity

Before using the material, confirm that the crimp cap is intact and shows no signs of decompression or physical damage. Well-preserved lyophilized powder has a uniform appearance — white or slightly off-white depending on the compound — with no moist patches and no cake collapse. A vial that arrived with a compromised seal cannot be taken as intact.

Certificate of analysis verification

Every PeptoClinic lot ships with a certificate of analysis from Janoshik Analytical — the third-party laboratory that performed the HPLC analysis. The certificate states the measured purity, the vial content, and a task number that allows direct verification of the report with the laboratory.

Published lots carry purities between 99.669 % and 99.893 %, all analyzed on April 13, 2026. The relevant figure for evaluating the integrity of a received lot is the purity of the specific lot that arrived, not a general average. Laboratories with recharacterization capability can run their own analysis on receipt — that as-of measurement is the definitive confirmation that the material arrived intact.

Published lot reports are available in the quality section.

For laboratory research only

The material PeptoClinic supplies is intended strictly for in vitro and laboratory research. It is not a medicine, not a supplement, and has not been evaluated by the FDA, ANMAT, or any equivalent regulatory authority for use in humans or animals.

PeptoClinic is not a pharmacy, not a clinic, and does not issue or require prescriptions. Inquiries about administration protocols, dosing, or cycling in people are outside the scope of this supply and are not answered.

That restriction is not a generic legal disclaimer: it defines what this material is and what it is for. The cold chain exists to preserve the chemical integrity of a compound that will be analyzed or used in a controlled research environment.

The full catalogue of research peptides available for quotation is at /en/catalog/.